Aristides Capital LLC Alector, Inc. Transaction History
Aristides Capital LLC
- $260 Million
- Q4 2024
A detailed history of Aristides Capital LLC transactions in Alector, Inc. stock. As of the latest transaction made, Aristides Capital LLC holds 106,600 shares of ALEC stock, worth $141,778. This represents 0.08% of its overall portfolio holdings.
Number of Shares
106,600Holding current value
$141,778% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding ALEC
# of Institutions
156Shares Held
55MCall Options Held
39.7KPut Options Held
51K-
Ra Capital Management, L.P. Boston, MA9.7MShares$12.9 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$12.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$7.47 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$2.55 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$2.46 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $110M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...